Bipolar II Disorder

Bipolar II disorder is a pattern of major depressive episodes and hypomanic episodes, without ever having full mania. Hypomania is a stretch of at least four days of raised energy and mood that other people can see but that doesn't wreck work or need a hospital. Because it can feel like a productive week, it often goes unreported, and bipolar II gets treated as plain depression. The depression itself tends to be the hardest part: frequent, long and sometimes persistent. Here is how bipolar II is recognized, why it gets missed, and how treatment differs from treating depression.

The two ingredients of bipolar II

The VA/DoD guideline defines bipolar II as at least one hypomanic episode and at least one major depressive episode, with no manic episode ever. The APA describes hypomania as lasting at least four days in a row; a major depressive episode lasts at least two weeks.

Both pieces are needed. Hypomania without depression is not bipolar II, and depression without any elevated episode is not bipolar disorder at all. If a full manic episode ever occurs, the diagnosis becomes bipolar I. See the bipolar I vs bipolar II comparison for the full picture, or our complete guide to bipolar disorder for every type.

What hypomania looks like in bipolar II

Hypomania brings the same kinds of change as mania, in a smaller dose: sleeping less without fatigue, more talk, more ideas, more plans, more confidence, sometimes irritability. There is no psychosis and no marked impairment. Friends may say "you seem different" or "you're a lot this week."

The trap is that hypomania often feels good, or at least useful. People rarely book an appointment to complain that they got a lot done. Our page on hypomania and the signs people miss goes through the checklist family members can help with.

Why bipolar II is mistaken for depression

NIMH puts it plainly: people with bipolar II may seek help only for depression, and the hypomanic episodes go unnoticed. The 2023 VA/DoD guideline adds that a depressive episode in bipolar disorder "is not reliably different" from one in major depression, so the diagnosis cannot be made from the depression alone.

The result is delay. A meta-analysis of 27 studies found an average of 5.8 years between onset and appropriate management (Dagani et al., 2017). In one survey of 600 people with bipolar disorder, 69% had first been misdiagnosed, most often with unipolar depression (Hirschfeld et al., 2003; a self-selected sample, so treat it as a signal rather than a rate).

This is why antidepressant labels tell prescribers to screen for a personal or family history of bipolar disorder before starting treatment. We cover that screening, and the questions to expect, on is it depression or bipolar disorder?.

The weight of the depression

For many people with bipolar II, depression is the illness. NIMH notes that many spend long periods in a persistent, low-grade depressive state, on top of full depressive episodes. The low periods are where work suffers, relationships strain and suicide risk climbs; an ISBD task force found suicide attempts in bipolar disorder were associated with depressive polarity, anxiety and substance use, among other factors.

Other conditions often come along. In national survey data, most people with bipolar disorder also had an anxiety disorder at some point (Merikangas et al., 2007). A meta-analysis found borderline personality disorder in about 37.7% of people with bipolar II (Fornaro et al., 2016), which matters because the two can look alike and are treated differently.

How common is bipolar II?

In the U.S. National Comorbidity Survey Replication (2001–2003 data), lifetime prevalence of bipolar II was about 1.1%, slightly higher than bipolar I at 1.0% (Merikangas et al., 2007). So bipolar II is not rare. Many more people had subthreshold bipolar symptoms that did not meet full criteria. See bipolar disorder statistics for the broader numbers.

Treatment options for bipolar II

Bipolar II is treated as bipolar disorder, not as depression. That usually means a mood-stabilizing medication, psychotherapy, and close attention to sleep and routine. Guideline positions, by name only:

• CANMAT/ISBD 2018 lists quetiapine as the only first-line option for acute bipolar II depression, and quetiapine, lithium and lamotrigine for bipolar II maintenance.
• Lumateperone (Caplyta) is FDA-approved for depression in bipolar I or II in adults; a 2023 evidence update to the CANMAT/ISBD guidelines placed it second-line.
• NIMH says antidepressants are not used alone in bipolar disorder; they may be added to a mood stabilizer or atypical antipsychotic. An ISBD task force found switch risk appears lower in bipolar II than in bipolar I, but caution still applies.
• The VA/DoD guideline suggests short-term light therapy as an add-on to medication for bipolar depression. In one trial, midday bright light added to antimanic medication led to remission in 68.2% versus 22.2% with placebo light (Sit et al., 2018). It should be clinician-guided, not self-started.
• Therapies with evidence include CBT, family-focused therapy, interpersonal and social rhythm therapy, and structured psychoeducation.

More detail is on treating bipolar depression. Ketamine, esketamine, TMS and ECT are not offered at Willow & Stone; when they are indicated for treatment-resistant depression, a referral is made.

As with bipolar I, stopping a mood stabilizer suddenly raises relapse risk, so changes should be planned with your prescriber.

If you suspect bipolar II: preparing for an evaluation

Because the diagnosis depends on remembering periods that may not have felt like a problem, a little preparation makes the first visit far more useful:

1. List any stretches of 4 or more days when you slept less, felt unusually confident or busy, or others said you seemed different. Approximate dates are fine.
2. Write down every antidepressant you have taken and how you reacted, especially any that left you agitated, wired or unable to sleep.
3. Ask relatives about bipolar disorder, depression, substance problems or suicide in the family.
4. Keep a simple daily log of mood, sleep and energy for a couple of weeks before the visit.
5. If you are comfortable, bring or invite someone who has known you through the ups and downs.

Self-screeners such as the Mood Disorder Questionnaire can help you put words to your experience, but they are screening tools, not a diagnosis.

Living with bipolar II

Many people with bipolar II are working, studying and caring for families while unwell, which can make the illness easy to hide and easy to under-treat. Helpful habits include a simple daily mood and sleep log, a regular sleep and wake time, limiting alcohol, and telling one trusted person what your early warning signs look like.

NIMH advises keeping a routine for eating, sleeping and exercise and keeping a life chart. Bring the chart to visits; it often answers questions memory can't.

At Willow & Stone

Dr. Stacey Forbes, PMHNP-BC, evaluates and treats bipolar II in Arlington, Texas and by telehealth, beginning with a 90-minute evaluation that looks closely at past highs, antidepressant responses and family history. See bipolar disorder treatment at Willow & Stone.

Common Questions

Sources & Further Reading

• VA/DoD Clinical Practice Guideline for the Management of Bipolar Disorder (2023)
• NIMH: Bipolar Disorder (NIH Pub. 25-MH-8088, revised 2025)
• American Psychiatric Association: What Are Bipolar Disorders?
• Dagani et al. Interval between onset and management of bipolar disorder (Can J Psychiatry 2017)
• Hirschfeld et al. NDMDA survey of people with bipolar disorder (J Clin Psychiatry 2003)
• Merikangas et al. Bipolar spectrum prevalence in the NCS-R (Arch Gen Psychiatry 2007)
• Fornaro et al. Borderline personality disorder and bipolar disorder (J Affect Disord 2016)
• Yatham et al. CANMAT and ISBD 2018 guidelines for bipolar disorder (Bipolar Disord 2018)

This article is general education, not a diagnosis or advice for your situation. Do not start, stop, or change a medication without talking to the clinician who prescribes it; stopping a mood stabilizer suddenly can trigger relapse.